newsfilter
← Latest News
GlobeNewswire·

Celsion and Hainan Poly Pharm Sign Agreement to Manufacture Celsion's DNA-based Vaccine

Expands GEN-1 Program Collaboration to Add Clinical and Commercial Batches of Investigational Vaccine LAWRENCEVILLE, N.J. and HAINAN, China, Sept. 17, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ:CLSN), a clinical-stage company focused on